Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies
Ali A. Rabaan(Saudi Aramco Medical Services Organization), Talha Bin Emran(Daffodil International University), Hussain Ali Al-fheid(Dammam Central Hospital), Mather F. Alhabib(Dammam Central Hospital), Yunus Effendi(Al-Azhar University), Trina Ekawati Tallei(Sam Ratulangi University), Fatimawali Fatimawali(Sam Ratulangi University), Mona A. Al‐Zaher, Esraa Z. Al‐Nass, Noor M. Al‐Sheef, Eba A. Al‐Ebrahim, Rinaldi Idroes(Universitas Syiah Kuala), Ahmad Akroman Adam(Sam Ratulangi University), Abdul Hawil Abas(Ghent University)
Cited by 63
Related Papers
Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
|Frontiers in Oncology|2022|531
Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study
|Scientifica|2020|272
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
|Frontiers in Cellular and Infection Microbiology|2022|241
Knowledge management practices in disaster management: Systematic review
|International Journal of Disaster Risk Reduction|2020|184